Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 20.80
-0.20 (-0.95%)
Feb 23, 2026, 4:09 PM CET
Navamedic ASA Revenue
In the year 2025, Navamedic ASA had annual revenue of 565.36M NOK with 6.38% growth. Navamedic ASA had revenue of 157.14M in the quarter ending December 31, 2025, with 19.77% growth.
Revenue
565.36M
Revenue Growth
+6.38%
P/S Ratio
0.89
Revenue / Employee
13.46M
Employees
42
Market Cap
503.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 565.36M | 33.92M | 6.38% |
| Dec 31, 2024 | 531.44M | 19.44M | 3.80% |
| Dec 31, 2023 | 512.00M | 129.86M | 33.98% |
| Dec 31, 2022 | 382.14M | 103.70M | 37.24% |
| Dec 31, 2021 | 278.44M | 68.56M | 32.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 662.18M |
| Nordhealth AS | 590.33M |
| Photocure ASA | 532.58M |
| Omda AS | 476.29M |
| Vistin Pharma ASA | 452.29M |
| Gentian Diagnostics ASA | 176.50M |
| ContextVision AB | 115.15M |
| Lytix Biopharma AS | 377.00K |
Navamedic ASA News
- 12 days ago - Navamedic ASA (OSL:NAVA) Q4 2025 Earnings Report Preview: What To Look For - GuruFocus